BioLight Life Sciences Investments (OTCQX:BLGTY; TASE:BOLT) is now defining itself as an ophthalmology company after spending several years assembling a cluster of investments in the sector as well as in cancer...
Search results for - TASE:Bolt
BioLight, Axella to advance CellDetect in bladder cancer
BioLight Life Sciences Investments’ (OTCQX:BLGTY; TASE:BOLT) cancer diagnostics subsidiary, Micromedic Technologies (TASE:MCTC), has entered into a collaboration agreement with Axella Research to advance the clinical...
BioLight in joint financing accord for IOPtima unit
BioLight Life Sciences Investments (OTCQX:BLGTY; TASE:BOLT) and two Asia-based venture capital firms have entered into a joint financing agreement for a direct equity investment in BioLight’s IOPtima subsidiary via a...
BioLight’s Eye-D to be featured at Boston conference
BioLight Life Sciences Investments’ (OTCQX:BLGTY; TASE:BOLT) Eye-D platform insert will be presented at the 5thAnnual Partnership Opportunities in Drug Delivery conference in Boston on Oct. 5. The Eye-D is BioLight’s...
